Young-Sun Sohn
Corporate Officer/Principal chez Catholic University of Korea
Profil
Young-Sun Sohn is a Professor at Catholic University of Korea.
Previously, he worked as the Chief Executive Officer at Abxign, Inc., Director-Biotechnology Research Center at Daewoong Pharmaceutical Co., Ltd., and Principal Scientist at CJ Corp.
Postes actifs de Young-Sun Sohn
| Sociétés | Poste | Début |
|---|---|---|
| Catholic University of Korea | Corporate Officer/Principal | 15/09/2011 |
Anciens postes connus de Young-Sun Sohn
| Sociétés | Poste | Fin |
|---|---|---|
Abxign, Inc.
 Abxign, Inc. Pharmaceuticals: MajorHealth Technology Abxign, Inc. was established in January 2008 and is located in Samsung Cancer Research building in Seoul National University. Abxign focused on the discovery and development of antibody therapeutics where by first or best-in-class therapies are introduced in large and growing markets with quality partners. Abxign has accumulated therapeutic antibody development technology and experience for many years and maintains relationships with domestic and foreign pharmaceutical companies specialized for each part of the development of antibody therapy. Based on these Abxign's network and technology, it will release the excellent antibodies in the world pharmaceutical market and extend the human life and contribute to improving the quality of life. | President | 25/07/2013 |
| CJ CORPORATION | Directeur Technique/Scientifique/R&D | - |
| DAEWOONG PHARMACEUTICAL CO., LTD | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| DAEWOONG PHARMACEUTICAL CO., LTD | Health Technology |
| CJ CORPORATION | Consumer Non-Durables |
| Entreprise privées | 1 |
|---|---|
Abxign, Inc.
Abxign, Inc. Pharmaceuticals: MajorHealth Technology Abxign, Inc. was established in January 2008 and is located in Samsung Cancer Research building in Seoul National University. Abxign focused on the discovery and development of antibody therapeutics where by first or best-in-class therapies are introduced in large and growing markets with quality partners. Abxign has accumulated therapeutic antibody development technology and experience for many years and maintains relationships with domestic and foreign pharmaceutical companies specialized for each part of the development of antibody therapy. Based on these Abxign's network and technology, it will release the excellent antibodies in the world pharmaceutical market and extend the human life and contribute to improving the quality of life. | Health Technology |